Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Bourne R. Re: Metabolomic prostate cancer fields in HRMAS MRS-profiled histologically benign tissue vary with cancer status and distance from cancer. Dinges et al, NBM 2019. NMR Biomed 2019;32:e4121. [PMID: 31184774 DOI: 10.1002/nbm.4121] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/07/2019] [Revised: 03/17/2019] [Accepted: 03/18/2019] [Indexed: 06/09/2023]

For:	Bourne R. Re: Metabolomic prostate cancer fields in HRMAS MRS-profiled histologically benign tissue vary with cancer status and distance from cancer. Dinges et al, NBM 2019. NMR Biomed 2019;32:e4121. [PMID: 31184774 DOI: 10.1002/nbm.4121] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/07/2019] [Revised: 03/17/2019] [Accepted: 03/18/2019] [Indexed: 06/09/2023]

Number

Cited by Other Article(s)

Cheng LL. Response to re: Metabolomic prostate cancer fields in HRMAS MRS-profiled histologically benign tissue vary with cancer status and distance from cancer. Dinges et al., NBM 2019. NMR IN BIOMEDICINE 2019;32:e4120. [PMID: 31172612 DOI: 10.1002/nbm.4120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2019] [Accepted: 04/30/2019] [Indexed: 06/09/2023]